1
|
Thomson CG, Aicher TD, Cheng W, Du H, Dudgeon C, Li AH, Li B, Lightcap E, Luo D, Mulvihill M, Pan P, Rahemtulla BF, Rigby AC, Sherborne B, Sood S, Surguladze D, Talbot EPA, Tameire F, Taylor S, Wang Y, Wojnarowicz P, Xiao F, Ramurthy S. Discovery of HC-7366: An Orally Bioavailable and Efficacious GCN2 Kinase Activator. J Med Chem 2024; 67:5259-5271. [PMID: 38530741 DOI: 10.1021/acs.jmedchem.3c02384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2024]
Abstract
A series of activators of GCN2 (general control nonderepressible 2) kinase have been developed, leading to HC-7366, which has entered the clinic as an antitumor therapy. Optimization resulted in improved permeability compared to that of the original indazole hinge binding scaffold, while maintaining potency at GCN2 and selectivity over PERK (protein kinase RNA-like endoplasmic reticulum kinase). The improved ADME properties of this series led to robust in vivo compound exposure in both rats and mice, allowing HC-7366 to be dosed in xenograft models, demonstrating that activation of the GCN2 pathway by this compound leads to tumor growth inhibition.
Collapse
Affiliation(s)
- Christopher G Thomson
- Integrated Drug Discovery Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - Thomas D Aicher
- Department of Chemistry, Lycera Corporation, Ann Arbor, Michigan 48103, United States
| | - Weiwei Cheng
- Pharmaron Beijing, Company Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China
| | - Hongwen Du
- Pharmaron Beijing, Company Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China
| | - Crissy Dudgeon
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - An-Hu Li
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Baozhong Li
- Pharmaron Beijing, Company Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China
| | - Eric Lightcap
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Diheng Luo
- Pharmaron Xi'an, Company Ltd., No. 1, 12th Fengcheng Road, Xi'an 710018, China
| | - Mark Mulvihill
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Pengwei Pan
- Pharmaron Beijing, Company Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China
| | - Benjamin F Rahemtulla
- Integrated Drug Discovery Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - Alan C Rigby
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Bradley Sherborne
- Integrated Drug Discovery Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - Sanjeev Sood
- Preformulation and Preclinical Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - David Surguladze
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Eric P A Talbot
- Integrated Drug Discovery Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - Feven Tameire
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Simon Taylor
- Integrated Drug Discovery Services, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, U.K
| | - Yi Wang
- Pharmaron Beijing, Company Ltd., No. 6, TaiHe Road, BDA, Beijing 100176, China
| | - Paulina Wojnarowicz
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| | - Fenfen Xiao
- Pharmaron Xi'an, Company Ltd., No. 1, 12th Fengcheng Road, Xi'an 710018, China
| | - Savithri Ramurthy
- HiberCell Inc., 619 West 54th Street, New York, New York 10019, United States
| |
Collapse
|
2
|
Afratis K, Bateman JM, Rahemtulla BF, Hughes O, Milgram BC, Mulhern TA, Talbot EPA. Regioselective Synthesis of Fully Substituted Fused Pyrroles through an Oxidant-Free Multicomponent Reaction. Org Lett 2023; 25:461-465. [PMID: 36638117 DOI: 10.1021/acs.orglett.2c03889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
The synthesis of fully substituted fused pyrroles through a multicomponent reaction between a thioamide, an aldehyde, and ammonium acetate is described. This process improves on a route commonly employed in the patent literature by avoiding the use of potentially hazardous oxidants, which cause the formation of side products and require a stringent process of derisking to be utilized on scale. The reaction proceeds under mild conditions, displays excellent functional group tolerance, and facilitates diversification through multiple vectors.
Collapse
Affiliation(s)
- Konstantinos Afratis
- Pharmaron Drug Discovery Services Europe, Pharmaron UK Ltd., Hertford Road, HoddesdonEN11 9FH, United Kingdom
| | - Joseph M Bateman
- Pharmaron Drug Discovery Services Europe, Pharmaron UK Ltd., Hertford Road, HoddesdonEN11 9FH, United Kingdom
| | - Benjamin F Rahemtulla
- Pharmaron Drug Discovery Services Europe, Pharmaron UK Ltd., Hertford Road, HoddesdonEN11 9FH, United Kingdom
| | - Oliver Hughes
- Pharmaron Drug Discovery Services Europe, Pharmaron UK Ltd., Hertford Road, HoddesdonEN11 9FH, United Kingdom
| | - Benjamin C Milgram
- Scorpion Therapeutics Inc., One Winthrop Square, Suite 400, Boston, Massachusetts02110, United States
| | - Thomas A Mulhern
- Vector CMC Consulting LLC, 5155 Trumpeter Dr., Portage, Michigan49024, United States
| | - Eric P A Talbot
- Pharmaron Drug Discovery Services Europe, Pharmaron UK Ltd., Hertford Road, HoddesdonEN11 9FH, United Kingdom
| |
Collapse
|
3
|
Bateman JM, Chan D, Moroglu M, Rahemtulla BF, Talbot EPA. Diastereoselective Synthesis of Morpholine Derivatives from Grignard Reagents and N-Sulfinyl Imines. Synlett 2021. [DOI: 10.1055/a-1529-4797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
AbstractThe stereoselective synthesis of substituted morpholine derivatives has been achieved through a two-step process involving diastereoselective addition of a Grignard reagent to a sulfinyl imine, followed by cyclization.
Collapse
|
4
|
Abstract
Hydrogen atom transfer-mediated intramolecular C-C coupling reactions between alkenes and nitriles, using PhSiH3 and catalytic Fe(acac)3 , are described. This introduces a new strategic bond disconnection for ring-closing reactions, forming ketones via imine intermediates. Of note is the scope of the reaction, including formation of sterically hindered ketones, spirocycles and fused cyclic systems.
Collapse
Affiliation(s)
- Oliver J Turner
- GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.,Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK
| | - John A Murphy
- Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK
| | - David J Hirst
- GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK
| | - Eric P A Talbot
- GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.,Present address: Pharmaron, Hertford Rd, Hoddesdon, EN11 9BU, UK
| |
Collapse
|
5
|
Abstract
The synthesis of pentafluorophenyl (PFP) sulfonate esters based on the Pd-catalyzed sulfination of aryl and heteroaryl boronic acids is reported. The sulfinate intermediates are converted in situ to the corresponding sulfonate esters using a copper-catalyzed oxidative process, providing a broad range of PFP esters in good yields.
Collapse
Affiliation(s)
- Vincent Vedovato
- Department of Chemistry , University of Oxford, Chemistry Research Laboratory , Mansfield Road , Oxford OX1 3TA , United Kingdom
| | - Eric P A Talbot
- GlaxoSmithKline Medicines Research Centre , Gunnels Wood Road , Stevenage SG1 2NY , United Kingdom
| | - Michael C Willis
- Department of Chemistry , University of Oxford, Chemistry Research Laboratory , Mansfield Road , Oxford OX1 3TA , United Kingdom
| |
Collapse
|
6
|
Griffiths RJ, Kong WC, Richards SA, Burley GA, Willis MC, Talbot EPA. Oxidative β-C-H sulfonylation of cyclic amines. Chem Sci 2018; 9:2295-2300. [PMID: 29719703 PMCID: PMC5897885 DOI: 10.1039/c7sc04900e] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Accepted: 01/19/2018] [Indexed: 12/12/2022] Open
Abstract
A new and efficient process to access β-functionalisation of cyclic amines via a mild oxidative β-sulfonylation.
A transition metal-free strategy for the dehydrogenative β-sulfonylation of tertiary cyclic amines is described. N-Iodosuccinimide facilitates regioselective oxidative sulfonylation at C–H bonds positioned β to the nitrogen atom of tertiary amines, installing enaminyl sulfone functionality in cyclic systems. Mild reaction conditions, broad functional group tolerance and a wide substrate scope are demonstrated. The nucleophilic character of the enaminyl sulfone is harnessed, demonstrating potential application for scaffold diversification.
Collapse
Affiliation(s)
- R J Griffiths
- GlaxoSmithKline Medicines Research , Gunnels Wood Road , Stevenage , Hertfordshire SG1 2NY , UK.,Department of Pure and Applied Chemistry , University of Strathclyde , 295 Cathedral Street , Glasgow , G1 1XL , UK
| | - W C Kong
- GlaxoSmithKline Medicines Research , Gunnels Wood Road , Stevenage , Hertfordshire SG1 2NY , UK.,Department of Chemistry , University of Oxford , CRL Mansfield Road , Oxford , OX1 3TA , UK .
| | - S A Richards
- GlaxoSmithKline Medicines Research , Gunnels Wood Road , Stevenage , Hertfordshire SG1 2NY , UK
| | - G A Burley
- Department of Pure and Applied Chemistry , University of Strathclyde , 295 Cathedral Street , Glasgow , G1 1XL , UK
| | - M C Willis
- Department of Chemistry , University of Oxford , CRL Mansfield Road , Oxford , OX1 3TA , UK .
| | - E P A Talbot
- GlaxoSmithKline Medicines Research , Gunnels Wood Road , Stevenage , Hertfordshire SG1 2NY , UK
| |
Collapse
|
7
|
Spencer JA, Jamieson C, Talbot EPA. One-Pot, Three-Step Synthesis of Cyclopropylboronic Acid Pinacol Esters from Synthetically Tractable Propargylic Silyl Ethers. Org Lett 2017; 19:3891-3894. [DOI: 10.1021/acs.orglett.7b01778] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Jonathan A. Spencer
- University of Strathclyde, 295 Cathedral
Street, Glasgow G1 1XL, U.K
- GlaxoSmithKline, Gunnels
Wood Road, Stevenage, Herts SG1 2NY, U.K
| | - Craig Jamieson
- University of Strathclyde, 295 Cathedral
Street, Glasgow G1 1XL, U.K
| | | |
Collapse
|
8
|
Thornbury RT, Saini V, Fernandes TDA, Santiago CB, Talbot EPA, Sigman MS, McKenna JM, Toste FD. The development and mechanistic investigation of a palladium-catalyzed 1,3-arylfluorination of chromenes. Chem Sci 2017; 8:2890-2897. [PMID: 28451354 PMCID: PMC5376715 DOI: 10.1039/c6sc05102b] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2016] [Accepted: 01/23/2017] [Indexed: 11/21/2022] Open
Abstract
A mild palladium-catalyzed ligand-controlled regioselective 1,3-arylfluorination of 2[H]-chromenes has been developed.
A mild palladium-catalyzed ligand-controlled regioselective 1,3-arylfluorination of 2[H]-chromenes has been developed. The products with a syn-1,3 substitution pattern were obtained with high enantiomeric excess using a PyrOx ligand, wherein the utility of these pyranyl-fluorides was further demonstrated through their participation in a diastereoselective C–C bond forming reaction. Ligand dependent divergent formation of both the 1,3- and 1,2- alkene difunctionalization products was observed. The nature of this bifurcation was investigated through experimental studies in combination with computational and statistical analysis tools. Ultimately, the site selectivity was found to rely on ligand denticity and metal electrophilicity, the electronics of the boronic acid, and the donor ability of the directing group in the substrate.
Collapse
Affiliation(s)
- Richard T Thornbury
- Department of Chemistry , University of California , Berkeley , California 94720 , USA .
| | - Vaneet Saini
- Novartis Institutes for Biomedical Research , Cambridge , Massachusetts 02139 , USA
| | - Talita de A Fernandes
- Department of Chemistry , University of California , Berkeley , California 94720 , USA . .,Instituto de Química , Universidade de Brasília , Campus Universitário Darcy Ribeiro , Caixa Postal: 04478 , 70904-970 , Brasília , DF , Brazil
| | - Celine B Santiago
- Department of Chemistry , University of Utah , Salt Lake City , Utah 84112 , USA
| | - Eric P A Talbot
- Department of Chemistry , University of California , Berkeley , California 94720 , USA . .,Novartis Institutes for Biomedical Research , Cambridge , Massachusetts 02139 , USA
| | - Matthew S Sigman
- Department of Chemistry , University of Utah , Salt Lake City , Utah 84112 , USA
| | - Jeffrey M McKenna
- Novartis Institutes for Biomedical Research , Cambridge , Massachusetts 02139 , USA
| | - F Dean Toste
- Department of Chemistry , University of California , Berkeley , California 94720 , USA .
| |
Collapse
|
9
|
Abstract
A metal-free strategy for the formation of lactams via selective oxidation of cyclic secondary and tertiary amines is described. Molecular iodine facilitates both chemoselective and regioselective oxidation of C-H bonds directly adjacent to a cyclic amine. The mild conditions, functional group tolerance, and substrate scope are demonstrated using a suite of diverse small molecule cyclic amines, including clinically approved drug scaffolds.
Collapse
Affiliation(s)
- Robert J Griffiths
- GlaxoSmithKline Medicines Research Centre , Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.,Department of Pure and Applied Chemistry, University of Strathclyde , 295 Cathedral Street, Glasgow G1 1XL, U.K
| | - Glenn A Burley
- Department of Pure and Applied Chemistry, University of Strathclyde , 295 Cathedral Street, Glasgow G1 1XL, U.K
| | - Eric P A Talbot
- GlaxoSmithKline Medicines Research Centre , Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K
| |
Collapse
|
10
|
Abstract
A mild catalytic asymmetric direct fluoro-arylation of styrenes has been developed. The palladium-catalyzed three-component coupling of Selectfluor, a styrene and a boronic acid, provides chiral monofluorinated compounds in good yield and in high enantiomeric excess. A mechanism proceeding through a Pd(IV)-fluoride intermediate is proposed for the transformation and synthesis of an sp(3) C-F bond.
Collapse
Affiliation(s)
- Eric P. A. Talbot
- Novartis
Institutes for Biomedical Research, Horsham,West Sussex, RH12
5AB, United Kingdom
- Department
of Chemistry, University of California, Berkeley, California 94720, United States
| | - Talita de A. Fernandes
- Department
of Chemistry, University of California, Berkeley, California 94720, United States
| | - Jeffrey M. McKenna
- Novartis
Institutes for Biomedical Research, Horsham,West Sussex, RH12
5AB, United Kingdom
| | - F. Dean Toste
- Department
of Chemistry, University of California, Berkeley, California 94720, United States
| |
Collapse
|
11
|
Abstract
A mild, catalytic, atom economical synthesis of imidazo[1,2-a]pyridines has been developed: catalytic PicAuCl2 in the presence of an acid produces a range imidazo[1,2-a]pyridines in good yield. This strategy is mild and forseen to be of particular use for the installation of stereogenic centers adjacent to the imidazo[1,2-a]pyridine ring without loss of enantiomeric excess.
Collapse
Affiliation(s)
- Eric P A Talbot
- Novartis Institute of Biomedical Research, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom ; Department of Chemistry, University of California, Berkeley, California 94720, United States
| | - Melodie Richardson
- Novartis Institute of Biomedical Research, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom
| | - Jeffrey M McKenna
- Novartis Institute of Biomedical Research, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom
| | - F Dean Toste
- Department of Chemistry, University of California, Berkeley, California 94720, United States
| |
Collapse
|
12
|
Hodgson DM, Talbot EPA, Clark BP. Synthesis of the anti-trypanosomal agent (±)-hydroxyanthecotulide by Cr(ii)-catalysed allylation and Meyer-Schuster rearrangement. Chem Commun (Camb) 2012; 48:6349. [PMID: 22614128 DOI: 10.1039/c2cc32283h] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2024]
Abstract
The first synthesis of the bioactive sesquiterpene lactone hydroxyanthecotulide is achieved in 7 steps, involving a stereocontrolled Cr(ii)-catalysed reaction of 3-(bromomethyl)furan-2(5H)-one with enynal 9 and a mild Au(i)-catalysed Meyer-Schuster rearrangement.
Collapse
Affiliation(s)
- David M Hodgson
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.
| | | | | |
Collapse
|
13
|
Abstract
The bioactive sesquiterpene lactone (+)-anthecotulide (1) is synthesized for the first time, in a six-step sequence devoid of protecting groups. The key transformations are a novel Rh(I)-catalyzed asymmetric enyne rearrangement of a terminal alkynyl ester (4), to form the α-methylene-γ-butyrolactone core, and a final-step mild Au(I)-catalyzed Meyer-Schuster rearrangement.
Collapse
Affiliation(s)
- David M Hodgson
- Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK.
| | | | | |
Collapse
|
14
|
Abstract
Zinc or a chromium(II) source with 3-(bromomethyl)furan-2(5H)-one (3) and an aldehyde gives β-(hydroxymethylaryl/alkyl)-α-methylene-γ-butyrolactones 5 in good yields and high diastereoselectivities. The methodology is demonstrated in concise syntheses of (±)-hydroxymatairesinol (8) and (±)-methylenolactocin (10) by subsequent arylboronate conjugate addition and translactonization, respectively.
Collapse
Affiliation(s)
- David M Hodgson
- Department of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
| | | | | |
Collapse
|